APA (7th ed.) Citation

M, C., A, S., & S, H. (2026). Anogenital cutaneous Crohn's disease: Effective treatment with interleukin-23 p19 inhibition in an under-recognized clinical entity. Journal of Crohn's & colitis, 20(4), . https://doi.org/10.1093/ecco-jcc/jjag047

Chicago Style (17th ed.) Citation

M, Colwill, Spencer A, and Honap S. "Anogenital Cutaneous Crohn's Disease: Effective Treatment with Interleukin-23 P19 Inhibition in an Under-recognized Clinical Entity." Journal of Crohn's & Colitis 20, no. 4 (2026). https://doi.org/10.1093/ecco-jcc/jjag047.

MLA (9th ed.) Citation

M, Colwill, et al. "Anogenital Cutaneous Crohn's Disease: Effective Treatment with Interleukin-23 P19 Inhibition in an Under-recognized Clinical Entity." Journal of Crohn's & Colitis, vol. 20, no. 4, 2026, https://doi.org/10.1093/ecco-jcc/jjag047.